PL197844B1 - Kompozycja farmaceutyczna do leczenia cukrzycy typu II i stanów związanych z cukrzycą typu II oraz zastosowanie - Google Patents

Kompozycja farmaceutyczna do leczenia cukrzycy typu II i stanów związanych z cukrzycą typu II oraz zastosowanie

Info

Publication number
PL197844B1
PL197844B1 PL338126A PL33812698A PL197844B1 PL 197844 B1 PL197844 B1 PL 197844B1 PL 338126 A PL338126 A PL 338126A PL 33812698 A PL33812698 A PL 33812698A PL 197844 B1 PL197844 B1 PL 197844B1
Authority
PL
Poland
Prior art keywords
compound
ozpusazaclacj
amount
notice
diabetes
Prior art date
Application number
PL338126A
Other languages
English (en)
Polish (pl)
Other versions
PL338126A1 (en
Inventor
Robin Edwin Buckingham
Stephen Alistair Smith
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of PL338126A1 publication Critical patent/PL338126A1/xx
Publication of PL197844B1 publication Critical patent/PL197844B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Communicable Diseases (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Oncology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
PL338126A 1997-07-18 1998-07-16 Kompozycja farmaceutyczna do leczenia cukrzycy typu II i stanów związanych z cukrzycą typu II oraz zastosowanie PL197844B1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9715295A GB9715295D0 (en) 1997-07-18 1997-07-18 Novel method of treatment
PCT/GB1998/002110 WO1999003477A1 (en) 1997-07-18 1998-07-16 Treatment of diabetes with thiazolidinedione, insulin secretagogue and diguanide

Publications (2)

Publication Number Publication Date
PL338126A1 PL338126A1 (en) 2000-09-25
PL197844B1 true PL197844B1 (pl) 2008-05-30

Family

ID=10816167

Family Applications (2)

Application Number Title Priority Date Filing Date
PL338126A PL197844B1 (pl) 1997-07-18 1998-07-16 Kompozycja farmaceutyczna do leczenia cukrzycy typu II i stanów związanych z cukrzycą typu II oraz zastosowanie
PL378474A PL198017B1 (pl) 1997-07-18 1998-07-16 Kompozycja farmaceutyczna przeciwcukrzycowa zawierająca tiazolidynodion i biguanidynowy środek antyhiperglikemiczny oraz jej zastosowanie

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL378474A PL198017B1 (pl) 1997-07-18 1998-07-16 Kompozycja farmaceutyczna przeciwcukrzycowa zawierająca tiazolidynodion i biguanidynowy środek antyhiperglikemiczny oraz jej zastosowanie

Country Status (39)

Country Link
EP (1) EP1001783B1 (enExample)
JP (2) JP2001510159A (enExample)
KR (1) KR100671918B1 (enExample)
CN (1) CN1264303A (enExample)
AP (1) AP1352A (enExample)
AR (1) AR016349A1 (enExample)
AT (1) ATE305790T1 (enExample)
AU (1) AU8448898A (enExample)
BG (1) BG64785B1 (enExample)
BR (1) BR9810445A (enExample)
CA (1) CA2296653C (enExample)
CO (1) CO4940420A1 (enExample)
CY (1) CY1105254T1 (enExample)
DE (1) DE69831808T2 (enExample)
DK (1) DK1001783T3 (enExample)
DZ (1) DZ2562A1 (enExample)
EA (1) EA003021B1 (enExample)
ES (1) ES2251093T3 (enExample)
GB (1) GB9715295D0 (enExample)
HU (1) HUP0003629A3 (enExample)
ID (1) ID24211A (enExample)
IL (1) IL134046A0 (enExample)
IN (1) IN189275B (enExample)
MA (1) MA24607A1 (enExample)
MY (1) MY155219A (enExample)
NO (1) NO325727B1 (enExample)
NZ (2) NZ501164A (enExample)
OA (1) OA11279A (enExample)
PE (1) PE99599A1 (enExample)
PL (2) PL197844B1 (enExample)
SA (1) SA98190468B1 (enExample)
SI (1) SI1001783T1 (enExample)
SK (1) SK285484B6 (enExample)
TR (1) TR200000134T2 (enExample)
TW (1) TW505516B (enExample)
UA (1) UA70303C2 (enExample)
UY (1) UY25102A1 (enExample)
WO (1) WO1999003477A1 (enExample)
ZA (1) ZA986363B (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6011049A (en) * 1997-02-19 2000-01-04 Warner-Lambert Company Combinations for diabetes
US6099862A (en) * 1998-08-31 2000-08-08 Andrx Corporation Oral dosage form for the controlled release of a biguanide and sulfonylurea
WO2000028989A1 (en) * 1998-11-12 2000-05-25 Smithkline Beecham P.L.C. Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent
SE9902918D0 (sv) * 1999-08-13 1999-08-13 Pharmacia & Upjohn Ab Methods for identification of compounds stimulating insulin secretion
MY125516A (en) * 1999-11-16 2006-08-30 Smithkline Beecham Plc Novel composition based on thiazolidinedione and metformin and use
JP2003514011A (ja) * 1999-11-16 2003-04-15 スミスクライン ビーチャム パブリック リミテッド カンパニー チアゾリジンジオン−塩酸メトホルミンを含む医薬組成物
FR2812547B1 (fr) * 2000-08-04 2002-10-31 Lipha Composition pharmaceutique comprenant une association metformine et derive de thiazolidinedione et son utilisation pour la preparation de medicaments destines a traiter le diabete
US7964216B2 (en) 2001-01-12 2011-06-21 Sun Pharma Advanced Research Company Limited Spaced drug delivery system
ITFI20010126A1 (it) * 2001-07-09 2003-01-09 Molteni & C Composizioni farmaceutiche per uso orale,contenenti,in combinazione,metformina e gliclazide
WO2003005995A1 (en) * 2001-07-10 2003-01-23 Aeropharm Technology Incorporated Core formulation comprising pioglitazone hydrochloride and a biguanide
PL376577A1 (pl) 2002-06-17 2006-01-09 Themis Laboratories Private Limited Wielowarstwowe tabletki zawierające tiazolidinedion i biguanidy oraz metody ich wytwarzania
ES2529180T3 (es) * 2002-09-20 2015-02-17 Andrx Labs Llc Formulación multietapa que contiene una biguanida y un derivado de tiazolidinodiona
UA80991C2 (en) 2002-10-07 2007-11-26 Solid preparation containing an insulin resistance improving drug and an active ingredient useful as a remedy for diabetes
TWI339586B (en) 2003-10-31 2011-04-01 Takeda Chemical Industries Ltd Solid preparation comprising pioglitazone or salt thereof,glimpiride and polyoxyethylene sorbitan fatty acid ester
MXPA05010977A (es) * 2005-10-12 2007-04-11 Abdala Leopoldo Espinosa Composiciones farmaceuticas que comprenden sustancias antidiabeticas combinadas para su uso en diabetes mellitus.
KR100812538B1 (ko) * 2006-10-23 2008-03-11 한올제약주식회사 약물 제어방출형 메트포르민-글리메피리드 복합제제
CN101417130B (zh) * 2007-10-22 2010-10-06 鲁南制药集团股份有限公司 一种治疗ⅱ型糖尿病及其并发症的药物组合物
WO2019078663A2 (ko) * 2017-10-20 2019-04-25 주식회사 노브메타파마 아연염, 시클로-히스프로 및 항당뇨 약물을 유효성분으로 함유하는 당뇨병 예방 또는 치료용 약학적 조성물

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5522636A (en) * 1978-08-04 1980-02-18 Takeda Chem Ind Ltd Thiazoliding derivative
JPS5697277A (en) * 1980-01-07 1981-08-05 Takeda Chem Ind Ltd Thiazolidine derivative
JPS6051189A (ja) * 1983-08-30 1985-03-22 Sankyo Co Ltd チアゾリジン誘導体およびその製造法
US4582839A (en) * 1984-03-21 1986-04-15 Takeda Chemical Industries, Ltd. 2,4-thiazolidinediones
CN1003445B (zh) * 1984-10-03 1989-03-01 武田药品工业株式会社 噻唑烷二酮衍生物，其制备方法和用途
JPH06779B2 (ja) * 1985-06-10 1994-01-05 武田薬品工業株式会社 チアゾリジオン誘導体およびそれを含んでなる医薬組成物
US4812570A (en) * 1986-07-24 1989-03-14 Takeda Chemical Industries, Ltd. Method for producing thiazolidinedione derivatives
US4791125A (en) * 1987-12-02 1988-12-13 Pfizer Inc. Thiazolidinediones as hypoglycemic and anti-atherosclerosis agents
FI904414A7 (fi) * 1988-03-08 1990-09-07 Pfizer Tiatsolidiinidioni-hypoglykeemisesti vaikuttavat aineet
WO1989008651A1 (en) * 1988-03-08 1989-09-21 Pfizer Inc. Hypoglycemic thiazolidinedione derivatives
WO1991007107A1 (en) * 1989-11-13 1991-05-30 Pfizer Inc. Oxazolidinedione hypoglycemic agents
JPH04210683A (ja) * 1990-12-06 1992-07-31 Terumo Corp チアゾリジン−２，４−ジオン誘導体およびこれを含有する糖尿病合併症治療薬
JPH06510286A (ja) * 1991-08-26 1994-11-17 ファルマシア・アンド・アップジョン・カンパニー ３−グアニジノプロピオン酸およびピオグリタゾン、グリベンクラミドまたはグリメピリドを含有する医薬組成物
US5917052A (en) * 1994-09-28 1999-06-29 Shaman Pharmaceuticals, Inc. Hypoglycemic agent from cryptolepis
TW438587B (en) * 1995-06-20 2001-06-07 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes
EP1671637A3 (en) * 1997-06-18 2007-12-19 SmithKline Beecham P.L.C. Treatment of diabetes with thiazolidinedione and sulphonylurea

Also Published As

Publication number Publication date
AR016349A1 (es) 2001-07-04
MY155219A (en) 2015-09-30
PL338126A1 (en) 2000-09-25
EP1001783A1 (en) 2000-05-24
DE69831808D1 (de) 2006-02-16
UA70303C2 (uk) 2004-10-15
NO325727B1 (no) 2008-07-07
AP1352A (en) 2004-12-24
PL198017B1 (pl) 2008-05-30
SK592000A3 (en) 2000-09-12
SK285484B6 (sk) 2007-02-01
CO4940420A1 (es) 2000-07-24
IL134046A0 (en) 2001-04-30
MA24607A1 (fr) 1999-04-01
BR9810445A (pt) 2000-09-05
KR100671918B1 (ko) 2007-01-22
GB9715295D0 (en) 1997-09-24
OA11279A (en) 2003-07-31
EP1001783B1 (en) 2005-10-05
SI1001783T1 (sl) 2006-02-28
ZA986363B (en) 2000-01-17
CA2296653A1 (en) 1999-01-28
TW505516B (en) 2002-10-11
KR20010021947A (ko) 2001-03-15
JP2001510159A (ja) 2001-07-31
WO1999003477A1 (en) 1999-01-28
HUP0003629A2 (hu) 2001-07-30
NZ501164A (en) 2001-06-29
SA98190468B1 (ar) 2007-01-20
PE99599A1 (es) 1999-12-18
CA2296653C (en) 2007-10-02
ES2251093T3 (es) 2006-04-16
NO20000228L (no) 2000-01-17
NZ511608A (en) 2002-12-20
NO20000228D0 (no) 2000-01-17
BG104135A (en) 2000-10-31
JP2005213273A (ja) 2005-08-11
AP2000001733A0 (en) 2000-03-31
DZ2562A1 (fr) 2003-02-15
TR200000134T2 (tr) 2000-09-21
DK1001783T3 (da) 2006-02-06
EA003021B1 (ru) 2002-12-26
ATE305790T1 (de) 2005-10-15
BG64785B1 (bg) 2006-04-28
CN1264303A (zh) 2000-08-23
CY1105254T1 (el) 2010-03-03
HUP0003629A3 (en) 2003-04-28
AU8448898A (en) 1999-02-10
DE69831808T2 (de) 2006-07-06
EA200000139A1 (ru) 2000-06-26
UY25102A1 (es) 2000-12-29
ID24211A (id) 2000-07-13
IN189275B (enExample) 2003-01-25
HK1028550A1 (en) 2001-02-23

Similar Documents

Publication Publication Date Title
US20070004780A1 (en) Treatment of Diabetes with Thiazolidinedione and Metformin
US20020004515A1 (en) Treatment of diabetes with thiazolidinedione and metformin
EP1001783B1 (en) Treatment of diabetes with thiazolidinedione, insulin secretagogue and diguanide
US20080058388A1 (en) Treatment of diabetes with thiazolidinedione and sulphonylurea
PL198018B1 (pl) Kompozycja farmaceutyczna przeciwcukrzycowa zawierająca sulfonylomocznik i tiazolidynodion i jej zastosowanie
EP1001784A1 (en) Treatment of diabetes with thiazolidinedione, insulin secretagogue and alpha glucosidase inhibitor
NZ501345A (en) Treatment of diabetes mellitus with 5-[4-[2-(N-methyl-N-(2- pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione (2-12 mg) and an alpha-glucosidase inhibitor antihyperglycemic agent
US20040122060A1 (en) Treatment of diabetes with thiazolidinedione, insulin secretagogue and diguanide
US20020052324A1 (en) Treatment of diabetes with thiazolidinedione, insulin secretagogue and alpha glucocidase inhibitor
US20020123514A1 (en) Treatment of diabetes with thiazolidinedione and alpha-glucosidase inhibitor
MXPA00000633A (en) Treatment of diabetes with thiazolidinedione, insulin secretagogue and diguanide
MXPA00000655A (en) Treatment of diabetes with thiazolidinedione, insulin secretagogue and alpha glucocidase inhibitor
HK1028550B (en) Treatment of diabetes with thiazolidinedione, insulin secretagogue and diguanide
MXPA99012078A (en) Treatment of diabetes with thiazolidinedione and metformin
AU2928002A (en) Treatment of diabetes with thiazolidinedione, insulin secretagogue and diguanide
AU2005227371A1 (en) Treatment of diabetes with thiazolidinedione, insulin secretagogue and diguanide

Legal Events

Date Code Title Description
LAPS Decisions on the lapse of the protection rights

Effective date: 20090716